Connect with us

News

100 MPs urge Government to fund medical cannabis prescriptions

Published

on

Children with severe epilepsy
Dozens of children have to rely on private medical cannabis prescriptions

In a joint letter, 100 cross-party politicians have called on the Prime Minister to provide urgent funding for families’ private prescriptions.

Since medical cannabis was legalised in 2018, it is thought that only three children in the UK have been granted NHS prescriptions.

Dozens of families of children with severe, treatment-resistant epilepsy are still forced to pay up to £2,000 a month for their children’s life saving medication. 

The letter, which has been signed by 100 MPs and Peers, calls for the Government to grant “compassionate funding” to help these families, until there is wider access on the NHS.

Labour MP Tonia Antoniazzi, chair of the All Parliamentary Group on Access to Medical Cannabis Under Prescription who authored the letter, said families were “emotionally and financially broken”.

The coronavirus crisis has restricted fundraising efforts leaving families carrying a “severe financial burden” and at risk of running out of medication “within weeks”.

Antoniazzi appealed to Boris Johnson to “grant access to some form of compassionate funding until the wider issues can be resolved”, the BBC reported on Friday 16 April.

A 2019 review carried out by the Department of Health into the blocks in issuing NHS prescriptions, called for an observational trial in which these children would have access to medical cannabis at no cost. 

But writing in The Times last week Antoniazzi said the APPG was informed that plans for the trial had been “effectively dropped”. 

The campaign group End Our Pain has called for the funding as a “short-term solution” to relieve some of the burden on these families. 

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.